BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16838203)

  • 21. Histological and Ultrastructural findings of regressing canine transmissible venereal tumor after repeated transplantation.
    Otomo K; Koike T; Kudo T; Sakai T
    Nihon Juigaku Zasshi; 1981 Dec; 43(6):823-32. PubMed ID: 7343693
    [No Abstract]   [Full Text] [Related]  

  • 22. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
    Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
    Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical application of an antibody specific for human CD1a to the diagnosis of canine mast cell tumour.
    Yhee JY; Hong SW; Yu CH; Doster AR; Blas-Machado U; Lyoo YS; Sur JH
    J Comp Pathol; 2008 Jul; 139(1):40-6. PubMed ID: 18602642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
    Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
    Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Observations on the transmissible venereal tumor (sticker) in the dog. A review of the tumors sent into the Institute for Animal Pathology of Ludwig-Maximilian University, Munich, from 1975 to 1987].
    Laging C; Kröning T
    Tierarztl Prax; 1989; 17(1):85-7. PubMed ID: 2470163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the tumour suppressor gene TP53 and expression of p53, Bcl-2 and p63 proteins in canine transmissible venereal tumour.
    Stockmann D; Ferrari HF; Andrade AL; Cardoso TC; Luvizotto MC
    Vet Comp Oncol; 2011 Dec; 9(4):251-9. PubMed ID: 22077405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis.
    Kleinschmidt S; Meneses F; Nolte I; Hewicker-Trautwein M
    Vet Immunol Immunopathol; 2007 Dec; 120(3-4):80-92. PubMed ID: 17850882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
    Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
    Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of angiogenesis in canine seminomas by quantitative immunohistochemistry.
    Restucci B; Maiolino P; Paciello O; Martano M; De Vico G; Papparella S
    J Comp Pathol; 2003 May; 128(4):252-9. PubMed ID: 12834608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice.
    Holmes JM
    Res Vet Sci; 1981 Mar; 30(2):248-50. PubMed ID: 7255917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial capture by a transmissible cancer.
    Rebbeck CA; Leroi AM; Burt A
    Science; 2011 Jan; 331(6015):303. PubMed ID: 21252340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
    Bautista-Gómez L; Martínez-Castañeda S
    Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
    Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
    Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of canine transmissible venereal tumour between two dogs in the UK.
    Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
    J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypic and molecular profile of cancer stem-cell markers in ex vivo canine transmissible venereal tumour (CTVT).
    Grandi F; Miot HA; Rocha RM; Gomes CMS; Queiroz-Hazarbassanov N; Montoya-Florez LM; Cogliati B; Rocha NS
    Vet Med Sci; 2022 Nov; 8(6):2297-2306. PubMed ID: 36098244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex disparity in oronasal presentations of canine transmissible venereal tumour.
    Strakova A; Baez-Ortega A; Wang J; Murchison EP
    Vet Rec; 2022 Sep; 191(5):e1794. PubMed ID: 35781651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.
    Chiang HC; Wang YS; Chou CH; Liao AT; Chu RM; Lin CS
    BMC Vet Res; 2012 Nov; 8():216. PubMed ID: 23136963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
    Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
    Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.